$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$2.24B
Market Cap
-
P/E Ratio
-1.76
EPS
$29.51
52 Week High
$2.86
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Olema Pharmaceuticals, Inc. is an innovative clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing targeted therapies for women's cancers. With a strong commitment to addressing significant unmet medical needs within this historically underrepresented patient population, Olema is advancing a promising pipeline of novel compounds designed to enhance patient outcomes. Positioned strategically within the oncology landscape, the company is currently navigating pivotal clinical trials, leveraging its scientific acumen to potentially reshape standard care practices in women's health. As it evolves, Olema remains dedicated to providing transformative treatment solutions that hold the potential to redefine the therapeutic landscape in this vital area of medicine.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG